Emerging Healthcare Solutions

Emerging Healthcare Solutions is a development-stage company that, through its subsidiary Celulas Geneticas, engages in the development and marketing of the Rutherford Procedure. The Rutherford Procedure is an organ regeneration treatment that uses proton beam technology to destroy diseased organ tissue in conjunction with the use of adult stem cells to regenerate organ tissue. The company is also developing iPhone applications such as the e-911 app, which automatically sends a user’s medical information to first responders when calling 911 from a mobile phone, and the AutoMed app, which calls users daily to remind them of the exact medication and dosage to take based on their doctor’s recommendations. Additionally, it holds rights to the DREAMS technology package.